PuraPharm Corporation Limited (1498.HK)
HKD 0.55
(-3.51%)
HKD 0.55
(-3.51%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 81.09 Million HKD | 66.58% |
| 2022 | 48.68 Million HKD | -47.09% |
| 2021 | 91.99 Million HKD | -48.6% |
| 2020 | 178.99 Million HKD | 24.55% |
| 2019 | 143.71 Million HKD | -2.98% |
| 2018 | 148.12 Million HKD | 172.9% |
| 2017 | 54.27 Million HKD | 0.0% |
| 2016 | - HKD | 0.0% |
| 2015 | - HKD | 0.0% |
| 2014 | - HKD | -100.0% |
| 2013 | 4.84 Million HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 105.93 Million HKD | 30.63% |
| 2023 Q2 | 44.37 Million HKD | -8.85% |
| 2023 FY | 81.09 Million HKD | 66.58% |
| 2023 Q4 | 81.09 Million HKD | 82.76% |
| 2022 FY | 48.68 Million HKD | -47.09% |
| 2022 Q4 | 48.68 Million HKD | -40.7% |
| 2022 Q2 | 82.08 Million HKD | -10.77% |
| 2021 FY | 91.99 Million HKD | -48.6% |
| 2021 Q4 | 91.99 Million HKD | -46.56% |
| 2021 Q2 | 172.13 Million HKD | -3.83% |
| 2020 Q4 | 178.99 Million HKD | 57.23% |
| 2020 Q2 | 113.84 Million HKD | -20.79% |
| 2020 FY | 178.99 Million HKD | 24.55% |
| 2019 FY | 143.71 Million HKD | -2.98% |
| 2019 Q4 | 143.71 Million HKD | 11.07% |
| 2019 Q2 | 129.39 Million HKD | -12.65% |
| 2018 Q4 | 148.12 Million HKD | 43.1% |
| 2018 FY | 148.12 Million HKD | 172.9% |
| 2018 Q2 | 103.51 Million HKD | 90.71% |
| 2017 FY | 54.27 Million HKD | 0.0% |
| 2017 Q4 | 54.27 Million HKD | -54.68% |
| 2017 Q2 | 119.76 Million HKD | 0.0% |
| 2016 Q4 | - HKD | 0.0% |
| 2016 FY | - HKD | 0.0% |
| 2016 Q2 | - HKD | 0.0% |
| 2015 FY | - HKD | 0.0% |
| 2015 Q4 | - HKD | 0.0% |
| 2015 Q2 | - HKD | 0.0% |
| 2014 FY | - HKD | -100.0% |
| 2014 Q4 | - HKD | 0.0% |
| 2013 FY | 4.84 Million HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -3811.869% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 91.809% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | 30.763% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | 70.64% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -14.804% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -124.904% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -533.49% |
| SSY Group Limited | 1.94 Billion HKD | 95.836% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -85.144% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | 86.306% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 99.512% |